Market Structure · July 31, 2026
Rotation narrows into earnings
Healthcare and financials carry the strongest relative trends. Energy's shorter burst looks less durable.
The thesis
Friday's radar shows a market rewarding sector rotation, but the leadership is uneven. Healthcare leads over three months with a 15.0% gain and 7.1 percentage points of relative strength versus the S&P 500. Financials follow with a 10.2% three-month gain and 6.3 points of relative strength. Those readings are broad enough to matter, yet the scan beneath them is concentrated around a small group of earnings dates from August 3 through August 5.
Energy requires a different reading. The sector gained 11.0% over one month but only 0.6% over three months, while losing 0.7% this week. That pattern points to a refining-margin burst rather than a settled leadership change. Healthcare and financials have the better intermediate evidence.
What the tape is rewarding
The scan covered 2,869 U.S.-listed securities. It favored established trends with near-term operating tests. Allstate traded at $265.38 after gaining 25.6% over three months, 3.3% below its 52-week high. Mitsubishi UFJ stood at $22.50 after a 29.0% three-month advance, also close to its high. Both sit inside the financial rotation without the one-month acceleration seen in refiners.
Healthcare has more breadth but also more extension. Thirteen of the top 25 scan results came from the sector. Several life-science tools names had already gained between 38% and 145% over three months. Revvity was the quieter exception: a 38.1% three-month advance followed by a 2.1% one-month gain. That pause gives its August 4 report more information value than another momentum print at a fresh high.
What the tape is rejecting
Technology lost 7.8% over one month, and industrials fell 3.7%. Consumer discretionary rose 3.3% this week but remains down 4.2% for the month and 3.6% over three months. Communication services is weaker still over three months at minus 7.3%. The radar produced no candidates from either lagging consumer discretionary or communication services. There is no evidence here for a broad return to the former growth leadership.
The scan also penalizes deals and vertical price moves. MarketAxess and Crinetics screened well mechanically after acquisition announcements, but their prices now reflect transaction terms rather than independent operating trends. Bruker and 10x Genomics gained 87.8% and 144.7% over three months. Those moves raise the evidence bar for the next company report.
Trigger and invalidation
The rotation thesis gains support if healthcare and financials hold their relative-strength leads after the August 3–5 earnings cluster, with reported margins and guidance matching the price action. Broader participation inside each group would strengthen the case.
The view weakens if those sectors lose relative strength as their reports arrive, especially if technology stabilizes after its 7.8% monthly decline. Energy would need strength beyond refiners and beyond one month to qualify as durable leadership. Until then, it remains a narrower margin cycle.
Method
This review uses July 31 market data across 2,869 securities. It combines sector returns, relative strength, volume, distance from 52-week highs, moving-average position, and dated company events. The radar identifies where attention is clustering. Company results determine whether that sponsorship survives new evidence.
Market analysis, not personalized investment advice.
Publisher Disclosure.
Curve Ahead Market Strategies publishes an impersonal business and financial publication of general and regular circulation.
The content is identical for all subscribers and is not tailored to any person’s portfolio, investment objectives,
risk tolerance, tax status, liquidity needs, or other circumstances. We do not provide individualized investment advice
through email, chat, customer support, social media, or any other channel. Any discussion of a security reflects the
publisher’s editorial views only and is not a request, instruction, or recommendation that any reader buy, sell,
hold, or use any specific investment strategy.
Conflicts & Compensation.
Principals, employees, or affiliates of the publisher may hold positions in securities discussed in this publication. Under the publisher’s personal-trading policy, principals do not trade a covered security from two trading days before through two trading days after the publisher posts coverage of that security, and where a principal holds a position in a security discussed, the publication states so.
Neither the publisher nor its principals, employees, or affiliates received compensation from any issuer, underwriter,
or dealer in connection with this publication. If any such compensation ever exists, the publication will clearly
disclose its source, amount, type, and timing.
Risk.
Investing involves risk, including possible loss of principal. Markets change; nothing described here is a prediction
or guarantee of any outcome.